Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:19 am Sale |
2024-12-31 | 13G | GH Research PLC GHRS |
FMR CORP | 2,487,370 4.800% |
-649,499 (-20.71%) |
Filing History |
| 2025-02-10 5:29 pm Purchase |
2025-02-06 | 13G | GH Research PLC GHRS |
Lynx1 Capital Management LP | 6,353,069 10.200% |
1,494,075 (+30.75%) |
Filing History |
| 2025-02-10 5:22 pm Purchase |
2024-12-31 | 13G | GH Research PLC GHRS |
Lynx1 Capital Management LP | 4,858,994 9.300% |
663,100 (+15.80%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 6,686,689 12.900% |
1,099,356 (+19.68%) |
Filing History |
| 2024-11-14 09:05 am Purchase |
2024-09-30 | 13G | GH Research PLC GHRS |
Lynx1 Capital Management LP | 4,195,894 8.100% |
1,201,835 (+40.14%) |
Filing History |
| 2024-02-16 4:57 pm Purchase |
2024-02-06 | 13G | GH Research PLC GHRS |
Lynx1 Capital Management LP | 2,994,059 5.800% |
2,994,059 (New Position) |
Filing History |
| 2024-02-14 8:34 pm Sale |
2023-12-31 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 1,318,327 2.500% |
-2,198,798 (-62.52%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 5,587,333 10.700% |
26,215 (+0.47%) |
Filing History |
| 2024-02-14 09:54 am Purchase |
2023-12-31 | 13G | GH Research PLC GHRS |
BIOTECHNOLOGY VALUE FUND L P | 10,400,158 19.990% |
1,125,000 (+12.13%) |
Filing History |
| 2024-02-14 07:04 am Purchase |
2023-12-31 | 13G | GH Research PLC GHRS |
RTW Investments, LP | 3,327,129 6.400% |
3,327,129 (New Position) |
Filing History |
| 2024-02-09 09:03 am Sale |
2024-02-08 | 13G | GH Research PLC GHRS |
FMR CORP | 3,136,869 6.030% |
-1,319,112 (-29.60%) |
Filing History |
| 2023-03-30 5:08 pm Purchase |
2023-03-28 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 5,561,118 10.700% |
662,745 (+13.53%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 4,898,373 9.400% |
2,054,616 (+72.25%) |
Filing History |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 3,517,125 6.800% |
696,624 (+24.70%) |
Filing History |
| 2023-02-10 4:35 pm Sale |
2022-12-31 | 13G | GH Research PLC GHRS |
Schonharting Florian | 14,824,419 28.500% |
-245,760 (-1.63%) |
Filing History |
| 2023-02-10 4:33 pm Sale |
2022-12-31 | 13G | GH Research PLC GHRS |
Terwey Theis H | 6,188,070 11.900% |
-235,830 (-3.67%) |
Filing History |
| 2023-02-09 10:59 am Sale |
2023-02-09 | 13G | GH Research PLC GHRS |
FMR CORP | 4,455,981 8.565% |
-746,513 (-14.35%) |
Filing History |
| 2022-05-27 4:05 pm Purchase |
2022-05-17 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% |
2,820,501 (New Position) |
Filing History |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | GH Research PLC GHRS |
FMR CORP | 5,202,494 10.000% |
111,929 (+2.20%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 2,843,757 5.500% |
-135,198 (-4.54%) |
Filing History |